| Family: | Amplify Investments |
| Name: | Amplify Weight Loss Drug & Treatment ETF |
| Inception Date: | 21-May-2024 |
| Termination Date: | |
| Investment Objective: | THNR provides access to global companies involved in the pharmaceutical manufacturing of GLP-1 agonist or enablers of such businesses. THNR seeks investment results that generally correspond to the performance (before fees and expenses) of the VettaFi Weight Loss Drug & Treatment Index. The Index is comprised of global companies who are manufacturers in the GLP-1 agonist (glucagon-like peptide) pharmaceutical business or who enable such business. GLP-1 agonists seek to lower blood sugar levels and reduce appetite and promote fullness, with the ultimate potential for weight loss. The Index seeks to identify companies associated with the manufacturing or supporting of GLP-1 agonists drugs that have the expectation to benefit economically from the development, approval or market adoption of GLP-1 agonist drugs. The Index begins with a universe of common stocks issued by companies located in developed countries around the world. |
| Prospectus | |
| Top 10 Holdings | ||
| Novo Nordisk A/S | NVO | 13.9300% |
| Eli Lilly & Co | LLY | 12.5500% |
| Amgen Inc | AMGN | 6.5600% |
| Regeneron Pharmaceuticals Inc | REGN | 6.3800% |
| Chugai Pharmaceutical Co Ltd | 4519 | 6.3200% |
| Merck & Co Inc | MRK | 5.3200% |
| Roche Holding AG | ROG | 5.1000% |
| Shionogi & Co Ltd | 4507 | 5.0700% |
| AstraZeneca PLC | AZN | 5.0700% |
| Innovent Biologics Inc | 1801 | 4.9700% |
| Top 10 Holdings Weight: | 71.3% |
| Number of Holdings: | 22 |
| Shares Outstanding: | 150,000 |
| Total Net Assets: | 3,921,750 |
| NAV: | 26.16 |
| Net Expense Ratio: | 0.59% |
| Asset Class: | Equities (Stocks) |
| Developed or Emerging: | Developed Market Funds |
| Country: | |
| Region: | |
| Strategy: | |
| Currency: | |
| Commodity: | |
| Sector: | Healthcare |
| Industry: | Pharmaceuticals |
| Dividend Type: | |
| Tax Exempt State: | |
| Maturity Duration: | |
| Market Cap: | Broad Market / Multi-Cap |
| Credit Quality: | |
| Mortgage Bond Types: | |
| Bond Type: | |
| Gov't Bond Types: | |
| Reit Type: | |
| Leverage Direction/Factor: | |
| Is Currency Hedged: | No |
| US or Ex-US: | Global |
